Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05618054 · ClinicalTrials.gov registry record · NA
Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Natural History With Its Numerous Co-morbidities?
A NA study of Postural Tachycardia Syndrome, sponsored by Virginia Commonwealth University.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT05618054 is a NA study of Postural Tachycardia Syndrome that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 36 participants, below the 81-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05618054, a NA study of Postural Tachycardia Syndrome, is actively recruiting participants, sponsored by Virginia Commonwealth University.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being conducted to see how people with Postural tachycardia syndrome (POTS) make sense of the things they see. The information may help doctors to learn more about how the different parts of people's brains communicate.
Conditions Studied
Interventions
- BEHAVIORAL Looming task
Study Locations (1)
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2023-03-06 |
| Est. Completion | 2026-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05618054
The ClinicalTrials.gov registry entry for NCT05618054 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 81-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (56% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postural Tachycardia Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Looming task is the first listed.
NCT05618054 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT05618054 about?
NCT05618054 is a clinical study titled "Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Natural History With Its Numerous Co-morbidities?". This study is being conducted to see how people with Postural tachycardia syndrome (POTS) make sense of the things they see. The information may help doctors to learn more about how the different parts of people's brains communicate.
What is the current status of trial NCT05618054?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2023-03-06. Estimated completion is 2026-03.
What conditions does trial NCT05618054 study?
This clinical trial studies the following conditions: Postural Tachycardia Syndrome.
What interventions are being tested in trial NCT05618054?
The interventions under investigation include: Looming task (BEHAVIORAL).
Who is sponsoring clinical trial NCT05618054?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05618054 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postural Tachycardia Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Autoimmune Basis for Postural Tachycardia Syndrome
RECRUITING · NA
-
Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)
ACTIVE NOT RECRUITING · NA
-
Acute Salt Handling in Orthostatic Intolerance
ACTIVE NOT RECRUITING · NA
-
fMRI in Postural Tachycardia Syndrome
ACTIVE NOT RECRUITING · NA
-
Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening
ACTIVE NOT RECRUITING · NA
-
Breathing Device in Postural Orthostatic Tachycardia Syndrome (POTS)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.